UCANACT secures €800,000 in pre-seed funding led by LUMO Labs and Utrecht Holdings Seed Fund to develop brain-computer interface technology for people with motor impairments.
Amount Raised
€800,000
Round Type
Pre-Seed
UtrechtInformation TechnologyBiotechnologySoftwareHealth CareArtificial IntelligenceMachine LearningHealth DiagnosticsInvestors
Description
Utrecht-based neurotechnology startup UCANACT has raised €800,000 in pre-seed funding to advance its brain-computer interface (BCI) technology that translates brain signals into computer actions and speech. The investment is led by LUMO Labs and Utrecht Holdings Seed Fund. UCANACT's BCI system analyzes brain activity and enables users with severe motor impairments to communicate independently, with demonstrated 90% accuracy for yes/no commands. The technology works with both brain implants and wearable devices, incorporating personalized AI to minimize user training requirements.
Quick answer
UCANACT raised €800,000 in a Pre-Seed round, dated September 20, 2026. Investors: LUMO Labs and Utrecht Holdings Seed Fund. UCANACT is based in Utrecht, Utrecht, Netherlands.
- How much did UCANACT raise?
- UCANACT raised €800,000 in a Pre-Seed round on September 20, 2026.
- Who invested in UCANACT?
- LUMO Labs and Utrecht Holdings Seed Fund are named as investors in this round.
- What does UCANACT do?
- UCANACT is a Utrecht-based neurotechnology startup developing brain-computer interface (BCI) technology that translates brain signals directly into computer actions and speech.
- Where is UCANACT based and how big is it?
- UCANACT is based in Utrecht, Utrecht, Netherlands. Fundz records about 2 employees.
- Who are the decision-makers at UCANACT?
- Fundz holds 1 contact at UCANACT, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as UCANACT that raised within 45 days of this round, from Fundz verified event records.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Scarlet raised $50M (Series B) on October 12, 2026.
- Cascader raised an undisclosed amount (Seed) on September 23, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
Who to call at UCANACT, and when
A new round usually means UCANACT is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day UCANACT raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at UCANACT, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at UCANACT. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment UCANACT raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
UCANACT raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.